MABRON RETARD 200mg prolonged-release tablets MEDOCHEMIE
tramadol Indicated for: moderate to severe pain
letter M · page 2
tramadol Indicated for: moderate to severe pain
tramadol Indicated for: moderate to severe pain
rituximab Indicated for: hematologic malignancies
rituximab Indicated for: hematologic malignancies
rituximab Indicated for: hematologic malignancies
rituximab Indicated for: hematologic malignancies
macitentan Indicated for: pulmonary arterial hypertension
macitentan Indicated for: pulmonary arterial hypertension
macitentan Indicated for: pulmonary arterial hypertension
macitentan Indicated for: pulmonary arterial hypertension
nifuratel Indicated for: mixed vaginal infections
nifuratel + nystatin Indicated for: fungal infections
nifuratel + nystatin Indicated for: fungal infections
pegaptanib sodium Indicated for: macular degeneration; diabetic macular edema
S01LA03 Sensory organs | Ocular vascular disorder agents | Antineovascularisation agents
pegaptanib sodium Indicated for: macular degeneration; diabetic macular edema
S01LA03 Sensory organs | Ocular vascular disorder agents | Antineovascularisation agents
levodopa + benserazide Indicated for: Parkinson's disease
N04BA02 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + benserazide Indicated for: Parkinson's disease
N04BA02 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + benserazide Indicated for: Parkinson's disease
N04BA02 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + benserazide Indicated for: Parkinson's disease
N04BA02 Nervous system | Dopaminergic agents | Dopa and dopa derivatives
levodopa + benserazide Indicated for: Parkinson's disease
N04BA02 Nervous system | Dopaminergic agents | Dopa and dopa derivatives